Two African swine fever virus proteins derived from a common precursor exhibit different nucleocytoplasmic transport activities by Eulálio, A. et al.
JOURNAL OF VIROLOGY, Sept. 2004, p. 9731–9739 Vol. 78, No. 18
0022-538X/04/$08.000 DOI: 10.1128/JVI.78.18.9731–9739.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Two African Swine Fever Virus Proteins Derived from a Common
Precursor Exhibit Different Nucleocytoplasmic
Transport Activities
A. Eula´lio,1,2 I. Nunes-Correia,1,2 A. L. Carvalho,1,3 C. Faro,1,2 V. Citovsky,4
S. Simo˜es,1,5 and M. C. Pedroso de Lima1,2*
Center for Neuroscience and Cell Biology of Coimbra,1 Department of Biochemistry2 and Department of Zoology,3
Faculty of Sciences and Technology, and Department of Pharmaceutical Technology, Faculty of Pharmacy,5
University of Coimbra, Coimbra, Portugal, and Department of Biochemistry and
Cell Biology, State University of New York, Stony Brook, New York4
Received 4 February 2004/Accepted 1 April 2004
African swine fever virus (ASFV), a large icosahedral deoxyvirus, is the causative agent of an economically
relevant hemorrhagic disease that affects domestic pigs. The major purpose of the present study was to
investigate the nuclear transport activities of the ASFV p37 and p14 proteins, which result from the proteolytic
processing of a common precursor. Experiments were performed by using yeast-based nucleocytoplasmic
transport assays and by analysis of the subcellular localization of different green fluorescent and Myc fusion
proteins in mammalian cells. The results obtained both in yeast and mammalian cells clearly demonstrated
that ASFV p14 protein is imported into the nucleus but not exported to the cytoplasm. The ability of p37 protein
to be exported from the nucleus to the cytoplasm of both yeast and mammalian cells was also demonstrated,
and the results clearly indicate that p37 nuclear export is dependent on the interaction of the protein with the
CRM-1 receptor. In addition, p37 was shown to exhibit nuclear import activity in mammalian cells. The p37
protein nuclear import and export abilities described here constitute the first report of a nucleocytoplasmic
shuttling protein encoded by the ASFV genome. Overall, the overlapping results obtained for green fluorescent
protein fusions and Myc-tagged proteins undoubtedly demonstrate that ASFV p37 and p14 proteins exhibit
nucleocytoplasmic transport activities. These findings are significant for understanding the role these proteins
play in the replication cycle of ASFV.
African swine fever virus (ASFV), one of the most complex
animal viruses, is the only member of the new family Asfarviri-
dae (10). This large enveloped virus is the causative agent of a
highly lethal hemorrhagic disease that affects domestic pigs (9,
42).
The ASFV genome is a large linear double-stranded DNA
molecule (170 to 190 kbp) that encodes more than 150
polypeptides, including about 50 structural proteins and sev-
eral enzymes involved in viral DNA replication, viral gene
transcription, and protein modification (41, 46).
Although ASFV has been considered for many years to be a
virus that replicates exclusively in the cell cytoplasm (9, 42), it
has been recently reported that an initial stage of its replication
cycle occurs inside the nucleus of infected cells (17, 32). It is
therefore reasonable to assume that some of ASFV proteins
must be actively transported between the nucleus and cyto-
plasm of host cells.
The bidirectional transport of macromolecules between the
nucleus and cytoplasm is a selective process that occurs exclu-
sively through nuclear pores. The nuclear pore complex is a
125-MDa macromolecular assembly of 50 to 100 polypeptides
that produces an aqueous channel with a diameter of 9 nm.
The channel allows the passive diffusion of small molecules,
including ions, metabolites, and globular proteins of up to ca.
60 kDa. Translocation of macromolecules larger than 60 kDa
into and out of the nucleus is an active, energy-dependent
process that is mediated by specific sequence motifs: nuclear
localization signals (NLSs) and nuclear export signals (NESs)
(6, 19, 28).
Classical examples of NLSs are the highly basic motifs found
in the simian virus 40 (SV40) large T antigen (22) and in
nucleoplasmin (31), although several nonclassical sequences
have also been shown to function as NLSs (11, 45).
The best-characterized NESs consist of short peptide se-
quences of four closely spaced hydrophobic amino acids, such
as leucine or isoleucine residues. These leucine-rich NESs
were initially identified in the human immunodeficiency virus
type 1 (HIV-1) Rev protein (13) and in the protein kinase A
inhibitor (43). However, NESs that do not belong to the family
of leucine-rich NESs have also been described for various
proteins, as exemplified by the atypical NES present in hepa-
titis D antigen HDAg-L (25).
The direct interaction of proteins bearing leucine-rich NESs
with the nuclear export factor CRM-1 (named for chromo-
some region maintenance 1; also known as exportin-1) is es-
sential for the nuclear export process (15, 16, 29, 39). NESs
present in proteins and RanGTP bind directly to CRM-1, and
this trimeric complex is then translocated from the nucleus to
the cytoplasm through the nuclear pore complex. Although the
CRM-1-dependent transport is the best-characterized path-
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way, CRM-1-independent nuclear export mechanisms have
been proposed for various proteins (12, 25, 26).
In the present study we examined the nuclear transport
capacity of two ASFV structural proteins—p14 and p37—
which are the result of the proteolytic processing of the pre-
cursor pp220 that is catalyzed by a viral protease that shares
sequence similarity with the proteases of the SUMO-1 family
(2, 33). Repression of protease expression inhibits polyprotein
processing, leading to the assembly of core-defective, nonin-
fectious viral particles (1).
The initial event of the proteolytic cascade is the separation
of the mature protein p150 and the precursor pp90; the cleav-
age of this precursor results in the mature protein p34 and in
preprotein pp55, which finally produces p37 and p14 (37).
Our results clearly demonstrate that ASFV p37 and p14
proteins are involved in nucleocytoplasmic transport. Interest-
ingly, although deriving from a common immediate precursor,
these proteins exhibit different transport activities. p14 protein
is imported into the nucleus, and p37 protein is both imported
into the nucleus and exported from the nucleus to the cell
cytoplasm, making it the first nucleocytoplasmic shuttling pro-
tein identified in ASFV. Moreover, we were able to determine
that p37 protein is exported from the cell nucleus through the
CRM-1-dependent nuclear export pathway.
MATERIALS AND METHODS
Plasmid constructs. cDNAs encoding p14 and p37 were amplified by PCR
with ASFV Lisbon 60 strain DNA as a template and with specific primers. The
primers introduced BamHI and NsiI recognition sites, respectively, at the 5 and
3 ends of the amplified DNA sequences. Each DNA fragment was cloned into
the BamHI/PstI restriction sites of either the plasmid for the yeast nuclear
import and export assays—pNIA and pNEA (30), respectively—or pCMV-Tag
3C (Stratagene, La Jolla, Calif.), as well as into pEGFP-C1 (Clontech, Palo Alto,
Calif.).
pNIAGFP and pNEAGFP were generated by cloning green fluorescent pro-
tein (GFP) cDNA downstream of the yeast Gal4p activation domain (Gal4AD)
in pNIA or pNEA, as follows. GFP cDNA was amplified by PCR, with
pEGFP-C1 as a template and with the primer pair 5-CGGGATCCCCATGGT
GAGCAAGG-3 and 5-CGGGATCCACTTGTACAGCTCGTC-3 that intro-
duced BglII and BamHI recognition sites. The amplified cDNA was then cloned
into the BamHI cloning site of pNIA or pNEA.
The primers used to generate pNIAGFPp14, pNEAp14, and Myc-p14 were
pri1 (5-GGATCCTTATGGACGAGGAGAAAACG-3) and pri2 (5-ATGCA
TCTAACCGCCTACCTTTGTA-3), the primers used to generate pNEAp37
and Myc-p37 were pri3 (5-GGATCCTTATGGCTGCCCTAACGG-3) and
pri4 (5-ATGCATCTAGCCTCCCAGTATCATA-3), the primers used to gen-
erate GFPp14 were pri5 (5-GGATCCATGGACGAGGAGAAAACG-3) and
pri2, and the primers used to generate GFPp37 were pri6 (5-GGATCCATGG
CTGCCCTAACGG-3) and pri4.
To construct GFPp37NLS, which encodes the classical SV40NLS (PKKKRKV)
fused to the C terminus of p37, PCR-based insertion was carried out by using the
QuickChange site-directed mutagenesis kit (Stratagene) according to the manufac-
turer’s instructions. To perform the insertion, GFPp37 (template) and the primer
5-CGCGTATGATACTGGGAGGCCCAAAAAAGAAGAGAAAGGTCATGC
ATTCGACGGTACCGCGGG-3 and its complementary oligonucleotide were
used.
GFPNLS was generated by the same strategy. pEGFP-C1 was used as a
template, and the primer 5-TACAAGTCCGGACTCAGATCTCCAAAAAAG
AAGAGAAAGGTCATGCATTCGACGGTACCGCGGG-3 and its comple-
mentary oligonucleotide were used to perform the insertion.
The constructs GFP-GFPp14 and GFP-GFPp37 were generated by PCR am-
plification with GFPp37 and GFPp14, respectively, as the template. The ampli-
fied cDNAs were introduced into BamHI and PstI restriction sites of pEGFP-C1.
The primer pair pri7 (5-GGATCCATGGTGAGCAAGG-3) and pri2 was used
to generate GFP-GFPp14, and the primer pair pri7 and pri4 was used to gen-
erate GFP-GFPp37.
The pNEARev (30) and pTat-GFP-NLS (40) plasmids have been described
previously.
Proper framing of all DNA constructs was confirmed by DNA sequencing
(AGOWA, Berlin, Germany).
Yeast nuclear import and export assays. The yeast nuclear import and nuclear
export assays were performed as described previously by Rhee et al. (30). Briefly,
pNIA and pNEA derived constructs were transformed into Saccharomyces cer-
evisiae strain L40, which contains the two LexA-inducible genes HIS3 and lacZ
(20), by the lithium acetate method (21). The transformed yeasts were then
plated on selective medium without tryptophan. Since pNIA and pNEA contain
the TRP1 gene, only transformed yeasts can grow on this medium.
After growth, a few colonies were spread on minimal medium without tryp-
tophan and in parallel were plated on minimal medium lacking both tryptophan
and histidine and supplemented with 10 mM 3-amino-1,2,4-triazole (3AT; Sigma,
St. Louis, Mo.), a repressor of yeast endogenous histidine production. For
pNEARev, minimal medium lacking both tryptophan and histidine was supple-
mented with 100 mM 3AT (30). Yeast growth in the absence of histidine was
evaluated.
In addition, yeasts plated on tryptophan-deficient medium were transferred to
nitrocellulose filters and assayed for -galactosidase activity (7). Briefly, after
disruption of yeast cell membrane by incubation at 70°C for 30 min, the yeast
lysate was incubated with the -galactosidase substrate X-Gal (5-bromo-4-
chloro-3-indolyl--D-galactopyranoside; Sigma), and blue color development was
evaluated.
For quantitative determination of -galactosidase activity, an enzymatic assay
was performed in liquid cultures (38). After growth in liquid medium without
tryptophan, yeast cells were disrupted, and the -galactosidase chromogenic
substrate ONPG (o-nitrophenyl--D-galactopyranoside; Sigma) was added in
excess. After incubation at 30°C, the reaction was stopped by raising the pH to
11, which inactivates -galactosidase. The -galactosidase activity was calculated
according to the following equation (27): -galactosidase units  1,000 
OD420/t  V  OD600, where OD420 is the optical density at 420 nm of the
sample measured after the incubation of yeast cell lysate with ONPG, t is the
time of incubation (in minutes) of the yeast cell lysate with ONPG, V is the
volume of the sample used in the assay (in milliliters), and OD600 is the optical
density at 600 nm of the yeast cell culture at the start of the assay.
Cell culture. Vero cells were grown and maintained in Dulbecco modified
Eagle medium–high glucose (DMEM-HG; Sigma) supplemented with 10% (vol/
vol) heat-inactivated fetal bovine serum (Biochrom KG, Berlin, Germany) and
with 100 U of penicillin and 100 g of streptomycin (Sigma) per ml in a 5% CO2
humidified atmosphere at 37°C.
For the transfection experiments, 7.5  104 Vero cells were seeded onto
16-mm glass coverslips on a 12-well plate.
Transfection, leptomycin B (LMB) treatment, and temperature shift assay.
Transfection experiments were performed by using transferrin-associated lipo-
plexes (35, 36) or Fugene 6 transfection reagent (Roche Molecular Biochemicals,
Penzberg, Germany) as follows.
The cationic liposome/transferrin/plasmid DNA complexes containing 1,2-
dioleoyl-3-trimethylammonium-propane (DOTAP) and cholesterol (1:1 molar
ratio; Avanti-Polar Lipids, Alabaster, Ala.) were prepared at a cationic lipid/
DNA (/) charge ratio of 1/1 as described previously (35, 36). For each
construct, 3 g of plasmid DNA per well was used. Vero cells at 50% confluence
were incubated with the complexes for 4 h in serum-free medium. After this, the
medium was replaced with DMEM-HG containing 10% fetal bovine serum, and
the cells were incubated another 24 h to allow gene expression.
Alternatively, Fugene 6 transfection reagent was used, according to the man-
ufacturer’s instructions, with 1 g of plasmid DNA per well.
Where indicated, cells were incubated with 20 ng of LMB (Sigma)/ml in
DMEM-HG for 3 h prior to fixation.
The temperature shift assay was performed by incubating transfected cells in
DMEM-HG containing cycloheximide (20 mg/ml; Sigma), a protein synthesis
inhibitor, for 1 h at 37°C, followed by 3 h of incubation on ice.
Fluorescence microscopy. For fluorescence analysis of GFP fusion proteins,
cells were washed with phosphate-buffered saline (PBS), fixed with 4% parafor-
maldehyde for 15 min, and rinsed with PBS.
For immunofluorescence analysis of Myc-tagged proteins, cells were washed
and fixed with 4% paraformaldehyde as described above. Cells were then per-
meabilized with 0.2% Triton X-100 for 2 min at room temperature, blocked with
3% bovine serum albumin in PBS at room temperature for 1 h, and incubated for
1 h at room temperature with anti-c-Myc monoclonal antibody (Roche Molec-
ular Biochemicals) diluted 1:100 in blocking solution. After an extensive wash
with PBS, cells were incubated with Alexa Fluor 488 goat anti-mouse immuno-
globulin G antibody (Molecular Probes Europe BV, Leiden, The Netherlands).
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For both direct and indirect fluorescence observations, the coverslips were
then inverted and mounted on glass slides with Vectashield mounting medium
(Vector Laboratories, Inc., Burlingame, Calif.). The slides were then visualized
by using a Bio-Rad MRC 600 fluorescence confocal microscope equipped with
an argon/krypton laser.
RESULTS
ASFV p37 protein is exported from the nucleus to the cyto-
plasm of yeast cells. To determine whether the ASFV p37
protein undergoes nuclear export, a yeast-based nuclear export
assay (30) was used. The rationale for this assay is the expres-
sion in yeast cells of a fusion protein encoded by pNEA, com-
prising mLexA (bacterial LexA modified to inactivate its in-
ternal NLS), SV40NLS (SV40 large T-antigen NLS), Gal4AD
(yeast Gal4p activation domain), and the protein to be tested,
subcloned in-frame downstream of Gal4AD. The expression of
the two reporter genes HIS3 and lacZ present in the S. cerevi-
siae strain L40 under the control of LexA (20) depends on the
intracellular localization of the tested fusion protein. If the
tested protein is not exported from the nucleus, the fusion
product is localized in the yeast cell nucleus due to the pres-
ence of SV40NLS. Yeast cells harboring this construct express
-galactosidase and grow in the absence of histidine as a con-
sequence of lacZ and HIS3 gene expression, respectively. On
the other hand, if the protein is exported, the fusion product is
redirected to the cell cytoplasm, at least partly abolishing the
-galactosidase activity and impeding growth on histidine-de-
ficient medium.
Figure 1a shows that yeast cells expressing the fusion prod-
uct containing the p37 protein (pNEAp37) did not grow in the
absence of histidine, indicating that the reporter HIS3 gene
was not activated. Accordingly, this construct did not induce
-galactosidase activity (Fig. 1a), strongly suggesting that p37
is exported from the nucleus to the cytoplasm of yeast cells.
In addition, by using the yeast-based nuclear export assay, it
was demonstrated that the precursor of both p37 and p14
proteins, the pp55 preprotein, is also exported from the nu-
cleus (data not shown).
Also presented in Fig. 1a are the results obtained for pNEA
and pNEARev, which were used as controls for the nuclear
export assay. pNEA encodes only the mLexA-SV40NLS-
Gal4AD fusion protein that is actively imported into the
nucleus, where it leads to maximal expression of the two
reporter genes. pNEARev encodes the fusion product con-
taining HIV-1 Rev protein (30), which is known to be exported
from the nucleus due to the presence of a leucine-rich NES.
When expressed in yeast cells, this fusion protein does not
induce either growth on histidine-deficient medium or -ga-
lactosidase activity, and therefore it was used as a positive
control for the assay.
Since the filter lift assay only provides a qualitative evalua-
tion of -galactosidase activity, the liquid culture assay was
used to quantify the activity of this enzyme in yeasts expressing
the different constructs. Yeast cells harboring pNEAp37
showed, similarly to pNEARev, significantly lower levels of
-galactosidase activity than that observed for the negative
control (pNEA) (Fig. 1b), further supporting the ability of p37
protein to undergo nuclear export in yeast cells.
The p37 protein encoded by ASFV is exported from the
nucleus of mammalian cells. To investigate the nuclear export
activity of p37 in a more biologically relevant system, studies in
ASFV host mammalian cells were performed. To this end, the
intracellular localization of GFPp37 fusion protein was deter-
mined by confocal fluorescence microscopy in Vero cells.
These experiments showed that GFP protein alone is dis-
tributed throughout the cell as a consequence of its low mo-
lecular weight, which allows its passive diffusion within the cell
(Fig. 2a).
In contrast, the GFPp37 fusion protein was localized exclu-
sively in the cytoplasm of transfected cells (Fig. 2c). This result
is consistent with our observations with the yeast-based nuclear
export assay and provides evidence that ASFV p37 protein is
FIG. 1. Assessment of the ability of ASFV p37 and p14 proteins to
be exported from the nucleus to the cytoplasm of yeast cells. (a)
Evaluation of yeast cell growth and -galactosidase activity. The
growth of L40 yeasts transformed with the indicated constructs was
analyzed both on selective medium without tryptophan (His) and on
medium without tryptophan and histidine (His) as described in Ma-
terials and Methods. The -galactosidase activity was evaluated by
using a colony-lift filter assay. Yeast cells expressing pNEAp37 showed
no growth in the absence of histidine and no -galactosidase activity.
Yeast cells expressing pNEAp14 exhibited growth on histidine dropout
medium and -galactosidase activity. (b) Quantitative -galactosidase
activity assay in liquid cultures. After cell growth in minimal medium
lacking tryptophan, the -galactosidase activity was determined as
described in Materials and Methods. Yeast cells transformed with
pNEAp37 showed residual values of -galactosidase activity, whereas
pNEAp14 induced -galactosidase activity levels similar to those of the
negative control pNEA. The data are expressed as a percentage of
maximal enzymatic activity obtained for pNEA alone; standard devi-
ations are shown based on quintuplicates of at least three independent
experiments.
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exported from the nucleus to the cytoplasm of mammalian
cells.
To confirm that the subcellular localization of p37 protein is
not a consequence of its fusion to GFP, a new construct of p37
protein tagged with the small epitope Myc was generated and
transfected into Vero cells. Similar to what was observed for
GFP-p37 (Fig. 2c), Myc-p37 was exclusively localized in the
cytoplasm (Fig. 3a), thus demonstrating both that p37 is ex-
ported and that GFP has no effect on the subcellular localiza-
tion of this protein.
To further confirm the nuclear export ability of p37 and to
evaluate the strength of this process, a slightly modified GFP
nuclear export assay (14, 39) was performed with a fusion
protein that contains the SV40NLS inserted at the C terminus
of p37 (GFPp37NLS). This assay explores the competition
between the nuclear import promoted by the SV40NLS and
the nuclear export capacity of p37 protein.
Vero cells transfected with GFPp37NLS construct displayed
fluorescence predominantly in the nucleus, although a signifi-
cant amount of the signal was detected in the cytoplasm (Fig.
4b), as opposed to what was observed for the control GFPNLS,
which is localized exclusively in the cell nucleus (Fig. 4a). This
result clearly indicates that the strength of p37 nuclear export
is sufficient to partially override the nuclear import mediated
by the SV40NLS.
Taken together, these results clearly demonstrate that p37
protein is exported from the nucleus to the cytoplasm of mam-
malian cells.
CRM-1 receptor mediates the nuclear export of ASFV p37
protein. To investigate the pathway involved in the nuclear
export of p37 protein, Vero cells expressing GFPp37 were
treated with LMB, a specific inhibitor of the CRM-1-depen-
dent nuclear export pathway (23).
The antibiotic LMB binds directly to a cysteine residue of
the CRM-1 receptor critical for the nuclear export (24), thus
abolishing its association with NESs and therefore specifically
inhibiting the nuclear export of proteins containing these sig-
nals.
As described above, cells expressing GFP alone presented
an uniform staining in both the nucleus and cytoplasm,
whereas in cells expressing GFPp37 the fluorescence is exclu-
sively localized in the cytoplasm (Fig. 2a and c). When cells
were treated with LMB, however, the control GFP remained
evenly distributed throughout the cell (Fig. 2b), whereas for
GFPp37 a dramatic change in its subcellular localization was
observed, resulting in its accumulation inside the nucleus of
transfected cells (Fig. 2d).
LMB treatment of cells expressing the Myc-p37 protein re-
sulted also in a nuclear accumulation of the protein (Fig. 3b),
supporting the involvement of CRM-1 receptor in the nuclear
export process of p37.
Cells expressing GFP-Tat-NES, the control for LMB activ-
ity, which contains both the NLS of HIV-1 Tat protein and the
leucine-rich NES of HIV-1 Rev protein (40), displayed an
exclusively cytoplasmic localization (Fig. 2e). In contrast, when
the nuclear export driven by the Rev NES was inhibited by
LMB, the fusion protein was localized inside the cell nucleus
(Fig. 2f). The observation of the same behavior for GFPp37
and Myc-p37 demonstrates that the CRM-1 pathway is respon-
sible for the nuclear export of p37 ASFV protein.
LMB treatment of cells expressing the fusion protein
GFPp37NLS abolished the cytoplasmic fluorescence observed
in the nontreated cells, leading to an exclusively nuclear local-
ization of the fusion protein (Fig. 4b and c). This finding proves
that the cytoplasmic fluorescence observed for nontreated cells
was due to a competitive effect of the NES present in p37,
further supporting that the nuclear export of p37 protein is
dependent on the CRM-1 receptor.
FIG. 2. Effect of LMB on the nuclear export ability of p37 protein.
Subconfluent cultures of Vero cells were transfected with the plasmids
encoding GFP, GFPp37, or GFP-Tat-NES. At 24 h after transfection,
cells were incubated or not incubated with LMB (20 ng/ml) for 3 h and
then fixed, and the subcellular localization of the different proteins was
visualized by fluorescence confocal microscopy as described in Mate-
rials and Methods. (a and b) GFP is distributed throughout the cell,
and its localization is not altered by LMB treatment. (c and d) In
untreated cells, GFPp37 fusion protein is localized exclusively in the
cytoplasm, whereas in LMB-treated cells GFPp37 accumulates inside
the nucleus. (e and f) GFP-Tat-NES fusion protein was used as a
control for the inhibitory activity of LMB on the nuclear export me-
diated by the HIV-1 Rev NES present in that construct.
FIG. 3. Effect of LMB on the subcellular localization of Myc-
tagged p37 protein. Vero cells were transfected with the expression
vector encoding Myc-p37. At 24 h after transfection, cells were either
left untreated or treated with 20 ng of LMB/ml for 3 h. Subcellular
localization of Myc-p37 was analyzed by immunofluorescence with an
antibody to the Myc epitope as described in Materials and Methods.
(a) Myc-p37 is localized in the cell cytoplasm. (b) Treatment of cells
with LMB induces nuclear accumulation of Myc-p37.
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ASFV p37 protein is a nucleocytoplasmic shuttling protein.
To clarify the process involved in the nuclear accumulation
observed for GFPp37 in the presence of LMB, studies of the
subcellular localization of GFPp37 at 4°C in the presence of a
protein synthesis inhibitor (to avoid de novo GFPp37 synthe-
sis) were performed. At this temperature all active transport
processes are blocked, whereas diffusion remains unaffected.
As opposed to what was observed upon incubation of cells
expressing GFPp37 at 37°C (Fig. 5a), fluorescence inside the
nucleus can be observed upon incubation of cells at 4°C (Fig.
5b), indicating that GFPp37 is able to diffuse between the
nucleus and the cytoplasm. Nonetheless, the nuclear fluores-
cence observed under this condition is significantly lower than
in cells treated with LMB at 37°C (Fig. 2d), strongly suggesting
that, in addition to diffusion, an active nuclear import process
is involved in the nuclear accumulation of GFPp37.
Therefore, to investigate the nuclear import ability of p37
protein, an additional construct was generated (GFP-GFPp37)
with a molecular weight of 91, clearly greater than the nuclear
pore diffusion exclusion limit. Accordingly, experiments per-
formed at 4°C demonstrated that the fusion protein GFP-
GFPp37 is not able to diffuse into the nucleus (compare Fig. 5c
to d). Nuclear accumulation of the nondiffusible GFP-GFPp37
protein (Fig. 5e) in cells treated with LMB demonstrates that
an active process is responsible for the entry of p37 into the
nucleus.
Overall, the results obtained clearly demonstrate the nucle-
ocytoplasmic shuttling capacity of p37 protein.
ASFV p14 protein is not exported from the nucleus to the
cytoplasm. In contrast to the results obtained for p37 protein
in the yeast nuclear export assay, the fusion product containing
p14 protein (pNEAp14) induced yeast cell growth on histidine
dropout medium and -galactosidase activity (Fig. 1a), indi-
cating that p14 protein does not undergo nuclear export.
FIG. 4. Competition assay between the nuclear import mediated by the SV40NLS and the nuclear export capacity of p37 protein. Vero cells
were transfected with GFPNLS or GFPp37NLS, and the subcellular localization of these fusion proteins was analyzed by fluorescence microscopy
in cells that were treated or not treated with LMB (20 ng/ml, 3 h) as described in Materials and Methods. (a) GFPNLS, a construct that contains
the SV40NLS but not a NES, presents an exclusively nuclear localization and is shown for comparison. (b) GFPp37NLS is found preferentially
in the nucleus of nontreated cells, but cytoplasmic localization is evident. (c) Treatment of cells with LMB leads to an exclusively nuclear
localization of the GFPp37NLS fusion.
FIG. 5. Effect of temperature shift and treatment with LMB on the subcellular localization of ASFV p37 fusion proteins. Vero cells were
transfected with GFPp37 or GFP-GFPp37. Where indicated, cells were treated with 20 ng of LMB/ml for 3 h. A temperature shift assay was
performed by treating the cells with a protein synthesis inhibitor for 1 h, followed by further incubation in the presence of the inhibitor, for 3 h
at 37°C (control) or 4°C as described in Materials and Methods. (a and c) At 37°C both GFPp37 and GFP-GFPp37 are localized exclusively in the
cytoplasm of transfected cells. (b and d) At 4°C, fluorescence inside the nucleus can be observed for cells expressing GFPp37. In contrast,
GFP-GFPp37 remains exclusively in the cytoplasm, indicating that this protein does not diffuse. (e) Upon treatment of cells expressing the
nondiffusible GFP-GFPp37 protein with LMB (20 ng/ml, 3 h at 37°C), nuclear accumulation is observed.
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The levels of -galactosidase activity quantified by the -ga-
lactosidase liquid culture assay were similar for yeast cells
expressing pNEAp14 and pNEA (Fig. 1b), confirming that the
fusion protein pNEAp14 is not exported, remaining inside the
nucleus where it activates the expression of the lacZ reporter
gene.
To extend the present study to mammalian cells, a fusion of
p14 and GFP proteins was expressed in Vero cells. Using
confocal fluorescence microscopy, GFPp14 fusion protein was
found to be localized both in the cytoplasm and nucleus, al-
though exhibiting a more pronounced nuclear localization
(Fig. 6a). Treatment of cells expressing GFPp14 with LMB had
no effect on the subcellular localization of the fusion protein,
as shown in Fig. 6b.
To exclude any effect of GFP on the subcellular localization
of p14 protein, a fusion of the epitope Myc with p14 protein
was also generated. Similar to what was observed for GFP p14,
Myc-tagged p14 protein was localized predominantly in the cell
nucleus (Fig. 6c), and its subcellular localization was not af-
fected by LMB treatment (Fig. 6d).
These findings corroborate the results obtained by using the
yeast nuclear export assay and, together, demonstrate that
ASFV p14 protein is not actively exported from the nucleus to
the cytoplasm in either yeast or mammalian cells.
ASFV p14 protein is imported to the nucleus of both yeast
and mammalian cells. Given the predominantly nuclear local-
ization of GFPp14 and Myc-p14 fusion proteins (Fig. 6a and c),
a yeast-based nuclear import assay (30) was used as a first
approach to determine whether p14 protein enters the nucleus
by an active process. This assay is similar to the yeast nuclear
export assay described above, except that the protein to be
tested was cloned into pNIA, a construct that does not contain
the SV40NLS, downstream of Gal4AD. As a consequence, the
triple fusion protein comprising mLexA, Gal4AD and the pro-
tein being tested is not able to enter the nucleus unless this
protein contains an NLS.
If the fusion protein is not imported into the nucleus, it does
not activate the expression of the reporter genes lacZ and
HIS3, and therefore the yeast cells do not grow on histidine-
deficient medium nor present -galactosidase activity. In con-
trast, if the tested protein is actively imported, the resulting
fusion protein enters the nucleus and, once there, activates the
expression of the two reporter genes, which results both in
-galactosidase activity and yeast growth on histidine-deficient
medium.
When expressed in yeasts, the pNIA-GFPp14 fusion protein
induced -galactosidase activity and growth on histidine-defi-
cient medium (Fig. 7a). Since this construct, due to the inser-
FIG. 6. Evaluation of the nucleocytoplasmic transport ability of
p14 protein in mammalian cells. Vero cells expressing either GFPp14,
Myc-p14, or GFP-GFPp14 were analyzed by fluorescence microscopy
24 h posttransfection as described in Materials and Methods. (a and c)
GFPp14 and Myc-p14 fusion proteins are predominantly localized in
the cell nucleus, although cytoplasmic fluorescence can be detected. (b
and d) LMB (20 ng/ml, 3 h) has no effect on the subcellular localization
of GFPp14 and of Myc-p14. (e) GFP-GFPp14 fusion protein accumu-
lates inside the nucleus of the transfected cells, although cytoplasmic
fluorescence can be observed.
FIG. 7. Evaluation of the nuclear import capacity of ASFV p14
protein in yeasts. (a) Evaluation of yeast cell growth and -galactosi-
dase activity. The growth of yeast cells transformed with the indicated
constructs was evaluated both on minimal medium with histidine but
lacking tryptophan (His) and on minimal medium lacking both tryp-
tophan and histidine (His) as described in Materials and Methods. A
-galactosidase colony-lift filter assay was performed in yeasts grown
on tryptophan-deficient medium. Yeast cells expressing pNIA-
GFPp14 show growth on medium without histidine and -galactosi-
dase activity. (b) The -galactosidase activity was quantified in liquid
cultures after yeast cell growth in minimal medium lacking tryptophan
as described in Materials and Methods. The data are expressed as a
percentage of maximal enzymatic activity obtained for pNEAGFP;
standard deviations are shown based on quintuplicates of at least three
independent experiments.
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tion of GFP between Gal4AD and p14, has a molecular weight
not compatible with diffusion across the nuclear pore, this
result indicates that p14 is actively imported into the nucleus.
pNIA-GFP and pNEA-GFP are the controls for the nuclear
import assay. pNIA-GFP encodes for the fusion protein
mLexA-Gal4AD-GFP and was used as negative control be-
cause it is not imported into the nucleus, resulting in minimal
expression of the two reporter genes (Fig. 7a), whereas pNEA-
GFP encodes the fusion protein mLexA-SV40NLS-Gal4AD-
GFP which, due to the presence of the SV40NLS, is actively
imported into the nucleus, leading to maximal activity of both
lacZ and HIS3 genes (Fig. 7a).
The results obtained by using the quantitative -galactosi-
dase assay show that pNIA-GFPp14 induced levels of -galac-
tosidase activity comparable to the high levels obtained for
pNEA-GFP (Fig. 7b), a finding which confirms that p14 pro-
tein is imported into the nucleus of yeasts.
The nuclear import ability of p14 was further confirmed in
mammalian cells by determining the subcellular localization of
the GFP-GFPp14 fusion protein, by fluorescence confocal mi-
croscopy. The fusion protein was localized both in the nucleus
and in the cytoplasm, but accumulation inside the cell nucleus
was clearly noticeable (Fig. 6e). Given the high molecular
weight of the GFP-GFPp14 fusion protein, its accumulation
inside the nucleus is clear evidence that p14 protein is im-
ported into the nucleus of mammalian cells.
DISCUSSION
Viral proteins are involved in numerous processes, including
the entry, morphogenesis, and egress of viruses, making the
detailed characterization of these proteins a key element to
better understand the different steps of infection.
The proteins studied here—p37 and p14, together with p34
and p150—are major structural ASFV proteins that are pro-
duced by sequential proteolytic processing of pp220 polypro-
tein precursor, which is a late protein synthesized after DNA
replication (37). These four proteins are located at the core
shell, which functions as a matrix domain between the DNA-
containing nucleoid and the inner envelope. Collectively, they
represent ca. 25% of the protein mass of the virus particle and
are present in an essentially equimolecular stoichiometry (3,
4).
The nuclear export ability of both p37 and p14 proteins was
assessed by using the described yeast-based nuclear export
assay. Using this strategy we were able to demonstrate that p37
protein, but not p14 protein, is exported from the nucleus of
yeast cells. However, p14 protein was imported into the nu-
cleus, as evaluated by the yeast-based nuclear import assay.
These results were validated in a more relevant biological
system by determining the intracellular localization of p37 and
p14 proteins fused to GFP or Myc, in mammalian cells, by
fluorescence confocal microscopy. In agreement with the re-
sults obtained in yeasts, p37 fusion proteins were detected
exclusively in the cell cytoplasm, whereas the fusions contain-
ing p14 protein were localized both in the nucleus and cyto-
plasm of mammalian cells, although exhibiting a preferential
localization inside the nucleus.
The overlapping results obtained for GFP fusions and Myc-
tagged proteins undoubtedly demonstrate that p14 and p37
proteins are responsible for the described nuclear transport
abilities.
The nuclear export observed for pp55 preprotein (data not
shown), which is the immediate precursor of p14 and p37
proteins, should be therefore attributed to p37 protein.
The nuclear accumulation of p37 fused with GFP or Myc
upon LMB treatment demonstrates that the nuclear export
exhibited by p37 protein is mediated by the CRM-1 pathway.
The nuclear import ability of p37 protein was evaluated with
a fusion protein with a molecular weight above the size limit
for diffusion through the nuclear pore complexes. Nuclear ac-
cumulation of this nondiffusible protein induced by cell treat-
ment with LMB clearly demonstrates that p37 is also imported
into the nucleus.
Although nuclear shuttling proteins have been identified in
many other viruses (8, 34, 40, 44), the findings reported here
show p37 protein to be the first nucleocytoplasmic shuttling
protein encoded by the ASFV genome.
The active transport of p14 protein to the nucleus demon-
strated by the yeast-based nuclear import assay was further
confirmed in mammalian cells by the determination of the
subcellular localization of a p14 fusion protein with a molec-
ular weight above the nuclear pore complex size exclusion
limit. In addition to p14 protein (and p37 protein), ASFV I14L
protein has been shown to be imported into the cell nucleus
(18). Nonetheless, the function of these proteins and the im-
portance of their nuclear import remain to be elucidated.
The generation from a common precursor of two proteins
(p14 and p37) exhibiting different nucleocytoplasmic transport
activities is, per se, interesting, although the wider biologic and
virologic significance of this fact is still unknown.
It has been demonstrated that fusion of SV40NLS with pro-
teins containing NESs that are localized in the cell cytoplasm
at the steady state, namely, HIV-1 Vpr (34) and hepatitis B
virus X protein (14), results either in an exclusively nuclear
localization or in a diffused staining pattern in the cytoplasm
and nucleus, respectively. Therefore, our observation of signif-
icant cytoplasmic fluorescence in cells transfected with
GFPp37NLS is in agreement with the observations for hepa-
titis B virus X protein (14), clearly indicating that the extent of
p37 nuclear export is high, overcoming the potency of the
SV40NLS.
To identify possible sequences responsible for the nuclear
import of p14 protein and for p37 protein nucleocytoplasmic
shuttling, sequence analysis of both proteins was performed.
This analysis resulted in the identification of several putative
leucine-rich NESs in p37 protein. However, the presence of
nonclassical NESs or of a nucleocytoplasmic bidirectional sig-
nal in this protein cannot be excluded. Studies are in progress
to test the functionality of the identified sequences and to
determine the signals responsible for the nuclear import of p14
and p37 proteins.
The lack of homology of ASFV p37 and p14 proteins with
other well-characterized proteins in databases makes any pre-
diction of their putative function difficult. Nonetheless, inter-
esting studies on the repression of the expression of their
pp220 precursor have demonstrated that pp220 or the products
of its proteolytic processing are essential for viral core assem-
bly and envelopment, as well as for the subsequent steps of
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core formation, including DNA encapsidation and nucleoid
maturation (5).
Immunofluorescence (37) and immunoelectron (4) micros-
copy studies do not report the presence of the products of
proteolytic processing of pp220 inside the nucleus of ASFV-
infected cells. However, it should be emphasized that these
studies were performed at late times of infection (12 to 18 h
postinfection), when virus assembly is already occurring.
Based on the existing data, a role for the nucleocytoplasmic
shuttling activity of p37 protein and for p14 protein nuclear
import at early stages of viral infection cannot be excluded,
especially considering the importance that the nucleocytoplas-
mic transport processes may have at an early stage of infection,
when the nuclear phase of ASFV DNA replication is occur-
ring. It is possible that p14 and p37 proteins are involved in the
formation of a complex with the viral DNA, facilitating its
entry into the nucleus, to initiate DNA replication. In an al-
ternative or complementary scenario, p37 protein could be
involved in the export of the viral genome from the nucleus to
the cytoplasm of infected cells after the brief nuclear replica-
tion phase. The localization of both p14 and p37 proteins in the
core shell of the viral particle supports these hypotheses, since
this would allow the interaction of these proteins with the viral
DNA.
Although additional studies are needed to elucidate the rel-
evance of the nucleocytoplasmic transport activities described
here to the function of p14 and p37 proteins, it is reasonable to
consider that this capacity must be critical for the role played
by these proteins in the replication cycle of the ASFV. Studies
are now under way to confirm the nucleocytoplasmic transport
activities of p14 and p37 proteins in ASFV-infected cells at
early times postinfection and to further elucidate the relevance
of this transport to the viral replication cycle.
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